Syros Pharmaceuticals Inc (SYRS)
5.11
+0.11
(+2.20%)
USD |
NASDAQ |
May 31, 16:00
5.10
-0.01
(-0.20%)
After-Hours: 20:00
Syros Pharmaceuticals Cash from Financing (Quarterly): -0.265M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.265M |
| December 31, 2023 | 43.38M |
| September 30, 2023 | -0.005M |
| June 30, 2023 | 0.14M |
| March 31, 2023 | -0.053M |
| December 31, 2022 | -10.70M |
| September 30, 2022 | 142.06M |
| June 30, 2022 | -0.223M |
| March 31, 2022 | -0.093M |
| December 31, 2021 | 0.096M |
| September 30, 2021 | -0.067M |
| June 30, 2021 | 0.072M |
| March 31, 2021 | 70.41M |
| December 31, 2020 | 110.80M |
| September 30, 2020 | 0.236M |
| June 30, 2020 | 0.22M |
| March 31, 2020 | 31.69M |
| December 31, 2019 | 1.089M |
| September 30, 2019 | -0.012M |
| Date | Value |
|---|---|
| June 30, 2019 | 65.03M |
| March 31, 2019 | -0.115M |
| December 31, 2018 | 0.137M |
| September 30, 2018 | 0.327M |
| June 30, 2018 | 16.45M |
| March 31, 2018 | 52.17M |
| December 31, 2017 | 0.692M |
| September 30, 2017 | -0.031M |
| June 30, 2017 | 33.15M |
| March 31, 2017 | 0.128M |
| December 31, 2016 | 0.024M |
| September 30, 2016 | 52.73M |
| June 30, 2016 | -0.564M |
| March 31, 2016 | 38.37M |
| December 31, 2015 | -0.582M |
| September 30, 2015 | -0.016M |
| June 30, 2015 | 0.32M |
| March 31, 2015 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-10.70M
Minimum
Dec 2022
142.06M
Maximum
Sep 2022
22.69M
Average
0.118M
Median
Cash from Financing (Quarterly) Benchmarks
| PDS Biotechnology Corp | 20.01M |
| PAVmed Inc | 19.05M |
| Moderna Inc | 14.00M |
| Altimmune Inc | -0.261M |
| iBio Inc | 5.025M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -31.10M |
| Cash from Investing (Quarterly) | -24.64M |
| Free Cash Flow | -103.90M |
| Free Cash Flow Per Share (Quarterly) | -0.7978 |
| Free Cash Flow Yield | -65.36% |